Median Technologies

The Company Provides Innovative FDA-Cleared and CE-Marked Lesion Management Solutions (LMSs) for Cancer Diagnosis and Follow-up.

Older News

SOPHIA ANTIPOLIS, NICE, France, November 29, 2010 - MEDIAN Technologies, the leading provider of clinical applications for quantitative management of treatment responses in oncology imaging, today announced that it had obtained "Innovative Company" accreditation from OSEO (the French state innovation agency).

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy